Vulnerable period in heart failure: a window of opportunity for the optimization of treatment – a statement by Mexican experts
Acute heart failure (HF) is associated with poor prognosis. After the acute event, there is a vulnerable period during which the patient has a marked risk of readmission or death. Therefore, early optimization of treatment is mandatory during the vulnerable period. The objective of this article is t...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioExcel Publishing Ltd
2024-01-01
|
| Sarja: | Drugs in Context |
| Aiheet: | |
| Linkit: | https://www.drugsincontext.com/vulnerable-period-in-heart-failure-a-window-of-opportunity-for-the-optimization-of-treatment-a-statement-by-mexican-experts/ |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
